International Precision Medicine Conference
March 13-15, 2025
Personalised medicine for CNS diseases
Diseases of the central nervous system (CNS) are on the rise all around the globe. The therapeutic medicines now in use to treat CNS diseases have a significant level of efficacy. However, these medications' inability to pass the blood–brain barrier, as well as the invasiveness of the technology used to enable localized drug delivery in disease, limit their use. -parts of the brain have thwarted painless and comprehensive CNS disease treatment. Neurological diseases cannot be treated with a coherent approach. These disorders, like all chronic diseases, are a complicated metabolic system involving the interaction of a patient's genes with their unique environment. As a result, precise and reliable testing procedures, such as patient biomarkers, age, and genetic history, are required.
- Oxidative stress
- Irreversible neurological disorders
- Rare neurological disorders
Roy Gary Beran
University of New South Wales, Australia
Ewa Danuta Bialek
Institute of Psychosynthesis, Poland
Sergey Suchkov
The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Jinyuan Zhou
Johns Hopkins University School of Medicine, United States
Wei Wu
UCSF, United States
Xu Chen
The College of St. Scholastica, United States
Styliani Geronikolou
University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece